Healthy Extracts reports Q3 results

Healthy Extracts Inc. (HYEX) reported Q3 GAAP EPS loss of $0.12, down from $0.06 a year ago. Revenue fell 32.5% Y/Y to $619,326, with net loss widening to $1.71M from $395,394.

Original reporting
Published Nov 17, 2026, 8:33 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 17, 2026, 8:40 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$HYEX
Bearish
medium confidence
Mentioned
$HYEX
Relevance
8/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$HYEXBearishMed
01

Why it matters

The disclosed deterioration in revenue and losses is the primary driver for trading focus, absent any guidance or balance-sheet/cash-flow details in the excerpt.

02

Market read

Traders can reassess near-term fundamentals and risk for HYEX based on the reported contraction in revenue and worsening GAAP losses.

03

What to watch

The excerpt lacks guidance, cash flow, and segment detail; traders should verify whether losses are driven by non-recurring items or cost actions.

Relevance 8/10Novelty 8/10Timing: pre-market today (Nov 17, 2026)

Background

The piece is a first report of Healthy Extracts’ Q3 results via its press release, including GAAP EPS, revenue, and net loss versus the prior year.

Company-level read

Ticker impact

$HYEXBearishMedium confidence
Context

Healthy Extracts reported Q3 GAAP EPS of -$0.12 and revenue down 32.5% Y/Y to $619,326, with net loss widening to $1.71M.

Expected impact

Likely downside bias as traders price in continued margin pressure and demand weakness.

Evidence & confidence

The article provides the company’s own quarterly EPS, revenue, and net loss figures, indicating deterioration versus the prior year.

Market effects

Limited spillover; this is a single small-cap earnings print with no sector-wide catalyst described.

No specific regional macro or cross-border linkage mentioned.

No global market linkage beyond the company’s own performance.

Counterpoint

Revenue decline could reflect timing or one-off channel disruptions, so the market may overreact if management frames it as temporary.

Key entities

  • Healthy Extracts Inc.

    Reported Q3 GAAP EPS loss, revenue decline, and wider net loss in its press release.

Related articles

$RIMEMed

Algorhythm Holdings Reports Third Quarter 2026 Financial Results

Algorhythm Holdings, Inc. (RIME) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Algorhythm Holdings Reports Third Quarter 2026 Financial Results Company Completes Azure Energy Acquisition and Begins Strategic Restructuring Fort Lauderdale, FL, November 17, 2026 – Algorhythm Holdings, Inc. (the “Company”) (NASDAQ: RIME ), a diversified holding co

$PULMMed

Pulmatrix Announces Third Quarter 2026 Financial Results and Progress on Merger

Pulmatrix, Inc. (PULM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Pulmatrix Announces Third Quarter 2026 Financial Results and Progress on Merger Merger with Eos SENOLYTIX expected to close by end of the year Framingham, Mass., November 17, 2026 – Pulmatrix, Inc. (“Pulmatrix”, the “Company” or “our”) (Nasdaq: PULM), a biopharmaceut